Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Serum glycoproteins in the liver diseases. III. Desialylated glycoproteins in the acute hepatitis.

Literature DB >> 892334

Serum glycoproteins in the liver diseases. III. Desialylated glycoproteins in the acute hepatitis.

T Arima, Y Motoyama, T Yamamoto, K Nagata, T Kondo.

Abstract

Circulating desialylated glycoprotein level in acute hepatitis was studied by using the competitive binding assay reported by us. Statistically significant differences of the level among acute hepatitis in the peak of illness, fulminating hepatitis and normal subjects were observed. The desialylated glycoprotein level in acute hepatitis was elevated associating with S-GPT and serum bilirubin levels, and it returned to the normal range before S-GPT and serum bilirubin were normalized. The desialylated glycoprotein in a fulminant hepatitis was increasing associated with bilirubin even when S-GPT was decreasing.

Entities: Chemical Disease

Mesh：

Substances：

Year: 1977 PMID： 892334 DOI： 10.1007/bf02773623

Source DB: PubMed Journal: Gastroenterol Jpn ISSN： 0435-1339

10 in total

1. Serum glycoproteins in the liver diseases. I. Studies on sialic acid-free glycoproteins-improved competitive binding assay of desialylated glycoprotein by rat liver plasma membrane.

Authors: T Arima; Y Motoyama; K Nagata; T Kondo
Journal: Gastroenterol Jpn Date: 1976

2. Chemical and physical properties of an hepatic membrane protein that specifically binds asialoglycoproteins.

Authors: T Kawasaki; G Ashwell
Journal: J Biol Chem Date: 1976-03-10 Impact factor: 5.157

3. Physical and chemical studies on ceruloplasmin. IX. The role of galactosyl residues in the clearance of ceruloplasmin from the circulation.

Authors: C J Van Den Hamer; A G Morell; I H Scheinberg; J Hickman; G Ashwell
Journal: J Biol Chem Date: 1970-09-10 Impact factor: 5.157

4. The binding of desialylated glycoproteins by plasma membranes of rat liver.

Authors: W E Pricer; G Ashwell
Journal: J Biol Chem Date: 1971-08-10 Impact factor: 5.157

5. The binding of desialylated glycoproteins by plasma membranes of rat liver. Development of a quantitative inhibition assay.

Authors: L Van Lenten; G Ashwell
Journal: J Biol Chem Date: 1972-07-25 Impact factor: 5.157

Review 6. Glycoproteins.

Authors: R G Spiro
Journal: Annu Rev Biochem Date: 1970 Impact factor: 23.643

5 in total

1. Ricinus communis agglutinin II-reactive glycoproteins from the ascites of patients with hepatocellular carcinoma and their use in enzyme-linked immunosorbent assay.

Authors: M Fukushima; T Arima; H Nagashima
Journal: Gastroenterol Jpn Date: 1987-04

5. Serum glycoproteins in the liver diseases. VI. The presence of desialylated glycoprotein binding activity in particulate fraction of human liver homogenate.

Authors: T Arima; T Kondo; H Nagashima
Journal: Gastroenterol Jpn Date: 1978

5 in total

Serum glycoproteins in the liver diseases. III. Desialylated glycoproteins in the acute hepatitis.

1. Serum glycoproteins in the liver diseases. I. Studies on sialic acid-free glycoproteins-improved competitive binding assay of desialylated glycoprotein by rat liver plasma membrane.

2. Chemical and physical properties of an hepatic membrane protein that specifically binds asialoglycoproteins.

3. Physical and chemical studies on ceruloplasmin. IX. The role of galactosyl residues in the clearance of ceruloplasmin from the circulation.

4. The binding of desialylated glycoproteins by plasma membranes of rat liver.

5. The binding of desialylated glycoproteins by plasma membranes of rat liver. Development of a quantitative inhibition assay.

Review 6. Glycoproteins.

7. Physical and chemical studies on ceruloplasmin. V. Metabolic studies on sialic acid-free ceruloplasmin in vivo.

8. Catabolism of desialylated ceruloplasmin in the liver.

9. The role of sialic acid in determining the survival of glycoproteins in the circulation.

10. Measurement of circulating desialylated glycoproteins and correlation with hepatocellular damage.

1. Ricinus communis agglutinin II-reactive glycoproteins from the ascites of patients with hepatocellular carcinoma and their use in enzyme-linked immunosorbent assay.

2. [Glycoproteins: their biological and clinical significance. II (author's transl)].

3. Serum glycoproteins in the liver diseases. VIII. Desialylated glycoproteins in the liver cirrhosis.

4. Serum glycoproteins in the liver diseases. V. Desialylated glycoproteins in chronic hepatitis.

5. Serum glycoproteins in the liver diseases. VI. The presence of desialylated glycoprotein binding activity in particulate fraction of human liver homogenate.